Skip to main content
Article thumbnail
Location of Repository

Estrogen and experimental ischemic stroke: a systematic review

By Claire L Gibson, Laura J. Gray, Sean Murphy and Philip M.W. Bath
Publisher: Nature Publishing Group
Year: 2006
OAI identifier: oai:eprints.nottingham.ac.uk:435
Provided by: Nottingham ePrints

Suggested articles

Citations

  1. (2004). 17 Β-Estradiol prevents focal cerebral ischemic damage via activation of Akt and CREB in association with reduced PTEN phosphorylation in rat. doi
  2. (1999). 17β-Estradiol reduces stroke injury in estrogen-deficient female animals.
  3. (1998). A
  4. (2001). A clinical trial of estrogen-replacement therapy after ischemic stroke.
  5. (2005). A systematic review of nitric oxide donors and L-arginine in experimental stroke; effects on infarct size and cerebral blood flow.
  6. (1997). American Heart Association Prevention Conference IV: prevention and rehabilitation of stroke: risk factors.
  7. (2005). Association between hormone replacement therapy and subsequent stroke: a meta-analysis. doi
  8. (1997). Bias in 600 meta-analysis detected by a simple graphical test. doi
  9. (1993). Cardiovascular Health and Disease in Women.
  10. (2004). Chronic behavioral testing after focal ischemia in the mouse: functional recovery and the effects of gender.
  11. (2000). Cognitive deficits after focal cerebral ischemia in mice.
  12. (1997). Correlation Between Motor Impairment and Infarct Volume After Permanent and Transient Middle Cerebral Artery Occlusion in the Rat.
  13. (1991). Decreased mortality in users of oestrogen replacement therapy.
  14. (1993). Decreased Risk of Stroke Among Postmenopausal Hormone Users.
  15. (2001). Deleterious effect of β-estradiol in a rat model of transient forebrain ischemia.
  16. (2004). Effects of combined estrogen and progesterone on brain infarction in reproductively senescent female rats.
  17. (1998). Effects of gender and estradiol treatment on focal brain ischemia. doi
  18. (2003). Estradiol attenuates programmed cell death after stroke-like injury.
  19. (2000). Estradiol exerts neuroprotective effects when administered after ischemic insult.
  20. (2001). Estradiol is a protective factor in the adult and aging brain: understanding of mechanisms derived from in vivo and in vitro studies.
  21. (1998). Estradiol protects against ischemic injury. doi
  22. (2000). Estradiol: A protective factor in the adult brain.
  23. (2003). Estrogen and ischemic neuroprotection: an integrated review. Trends Endocrinol Metab.
  24. (2003). Estrogen and Stroke. A balanced analysis.
  25. (2000). Estrogen as a neuroprotectant in stroke.
  26. (2000). Estrogen decreases infarct size after temporary focal ischemia in a genetic model of type 1 diabetes mellitus.
  27. (2002). Estrogen is neuroprotective via an Apolipoprotein E-dependent mechanism in a mouse model of global ischemia.
  28. (2001). Estrogen receptor α, not β, is a critical link in estradiol-mediated protection against brain injury. doi
  29. (1998). Estrogen-mediated neuroprotection after experimental stroke in male rats.
  30. (2002). Estrogens and neuroprotection.
  31. (2001). Estrogens decrease reperfusion-associated cortical ischemic damage.
  32. (1997). Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat.
  33. (2005). Estrogens, progestins, menopause and neurodegeneration: basic and clinical studies.
  34. et al (2001) 17-β estradiol can reduce secondary ischemic damage and mortality of subarachnoid hemorrhage. doi
  35. et al (2003) 17[beta]-Estradiol extends ischemic thresholds and exerts neuroprotective effects in cerebral subcortex against transient focal cerebral ischemia in rats.
  36. (2003). Examination of sensorimotor performance following middle cerebral artery occlusion in rats.
  37. (2000). Gender differences and the effects of synthetic exogenous and non-synthetic estrogens in focal cerebral ischemia.
  38. (2001). Hormone replacement therapy and ischemic stroke severity in women. doi
  39. (1997). Hormone replacement therapy and risk of non-fatal stroke.
  40. Kotchen et al (2003) Effect of estrogen plus progestin on stroke in postmenopausal women -The Women's Health Initiative: A randomized trial.
  41. (2002). Loss of benefit from estrogen replacement therapy in diabetic ovariectomized female rats subjected to transient forebrain ischemia.
  42. (1992). Neurological and behavioural outcomes of focal cerebral ischemia in rats.
  43. (2001). Neuroprotection by estradiol.
  44. (1999). Neuroprotection by estrogens in a mouse model of focal cerebral ischemia and in cultured neurons: evidence for a receptor-independent antioxidative mechanism. doi
  45. (2002). Neuroprotective effects of a novel non-receptor-binding estrogen analogue.
  46. (2001). Neuroprotective effects of estradiol in middle-aged female rats. doi
  47. (2000). Neuroprotective effects of estrogens: potential mechanisms of action.
  48. (2000). Neuroprotective effects of female gonadal steroids in reproductively senescent female rats. doi
  49. (2001). Nimodipine in animal model experiments of focal cerebral ischemia.
  50. (2000). Ovariectomy exacerbates and estrogen replacement attenuates photothrombotic focal ischemic brain injury in rats.
  51. (2001). Postischemic estrogen reduces hypoperfusion and secondary ischemia after experimental stroke.
  52. (2002). Progesterone Administration During Reperfusion, But Not Preischemia Alone, Reduces Injury in Ovariectomized Rats.
  53. (2004). Progesterone enhances functional recovery following middle cerebral artery occlusion in male mice.
  54. (2005). Progesterone suppresses the inflammatory response and nitric oxide synthase-2 expression following cerebral ischemia.
  55. (2001). Reduction in infarct size by local estrogen does not prevent autonomic dysfunction after stroke.
  56. (1992). Secular trends in stroke incidence and mortality.
  57. (2004). Stroke in the Female: Role of Biological Sex and Estrogen.
  58. (1999). Stroke Therapy Academic Industry Roundtable
  59. (1998). Testosterone increases and estradiol decreases middle cerebral artery occlusion lesion size in male rats.
  60. (1994). The incidence, prevalence and mortality of cardiovascular disease. In: The Heart (Schlant RC, Alexander RW,
  61. (2001). The nonfeminizing enantiomer of 17B-Estradiol exerts protective effects in neuronal cultures and a rat model of cerebral ischemia.
  62. (2003). The use of estrogens and related compounds in the treatment of damage from cerebral ischemia. doi
  63. (2003). WHI: Now that the dust has settled. A commentary. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.